Alcohol Consumption Emerges as a Key Risk Factor for Buccal Cancer in India
December 24, 2025
Brand Name :
Revlimid
Synonyms :
Class :
Antineoplastic agents; Angiogenesis Inhibitors
Dosage forms & Strengths:
Capsule:
2.5 mg
5 mg
10 mg
15 mg
20 mg
25 mg
10 mg orally each day
Continue the treatment until the disease is reduced to acceptable toxicity
25 mg orally each day on the initial 21 days of the 28 days cycle
25 mg orally each day on the initial 21 days of the 28 days cycle
25 mg orally each day on the initial 21 days of the 28 days cycle
20 mg orally each day on the initial 21 days of the 28 days cycle
Safety and efficacy are not seen in pediatrics
lenalidomide increases the severity of the formation of fatal blood clots when taken along with peginesatide
risk and life-threatening effects occur when nivolumab is co-administered with lenalidomide for treating multiple myeloma
when both drugs are combined, there may be an increased risk of severe and life-threatening side effects as well as death
they increase the toxicity of bisphosphonate derivatives
they increase the toxicity of bisphosphonate derivatives
they increase the toxicity of bisphosphonate derivatives
they increase the toxicity of bisphosphonate derivatives
may have an increased thrombogenic effect when combined with lenalidomide
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives
may increase the thrombogenic effect of Erythropoiesis-Stimulating Agents
>10%
Thrombocytopenia
Neutropenia
Diarrhea
Pruritus
Nausea
Rash
Fatigue
Arthralgia
Back pain
Peripheral edema
Pyrexia
Dizziness
Headache
Cough
Muscle cramp
Dyspnea
URTI
Anemia
Pneumonia
UTI (11%)
1-10%
Abdominal pain
Leukopenia
Myalgia
Pain
Bronchitis
Rhinitis
Febrile neutropenia
Peripheral neuropathy
Lenalidomide is contraindicated in patients hypersensitive to the formulation’s active ingredient and other excipients.
Pregnancy consideration: The drug is contraindicated during pregnancy
Breastfeeding warnings: Women are advised not to breastfeed while administering lenalidomide.
Pregnancy category:
Patient information leaflet
Generic Name: lenalidomide
Pronounced: leh-nuh-LIH-doh-mide
Why do we use lenalidomide?
Lenalidomide is an anticancer agent used to treat myelodysplastic syndromes, multiple myeloma, mantle cell lymphoma, and follicular lymphoma.